Software stocks experience worst selloff in nearly 3 years as tech continues to get beaten up
Software ETF sinks 5.4%, worst day since February 2016
All Posts in "Market Watch"
Asian stocks drop as tech pullback, Nissan CEO’s arrest takes toll
Auto, electronics sectors weigh Nikkei; tech stocks sink Hang Seng
Asian markets quiet as U.S.-China trade tensions linger
Nikkei up slightly, Hang Seng gives up early gains
Sonos offers teaser for new line of products as shares rocket 10%
Promise of a line of products for outside the home welcomed by analysts who are worried about growing competition
Why people are paying $7 and up for this fancy new tea latte
From lattes to cookies, matcha powder is making its presence known
Zuckerberg’s tougher management style drove away Facebook execs, raised tension with Sandberg: report
Facebook CEO reportedly on war footing as criticism toward the company mounts
Nordstrom’s profit takes a hit after credit-card-interest error
Nordstrom shares slumped 13% in Friday trading after the retailer took a 28-cents-per-share charge in the third quarter
Fortnite ‘V-Bucks’ more popular than cash on teens’ holiday wish lists
Young people are also lusting after Gucci and Apple products this holiday season.
If you’re worried about retiring at a stock-market top, this might help
Don’t get caught up in market timing
European stocks dragged lower by tech, Brexit concerns
ASML, AstraZeneca among the big decliners
Weekly Market Review – December 21, 2024
Weekly Market Review – December 21, 2024
Medtronic appoints new chief medical officer for digital surgery and robotics
Neurocrine’s bid to save schizophrenia prospect fails
FDA greenlights over-the-counter hearing aid features for Apple’s AirPods
Oncternal folds all clinical trials after lackluster data drop, patient death
Zenas, MBX and Bicara all head to Nasdaq in hot day for biotech IPOs
FDA pushed to be more open, collaborative to accelerate rare disease R&D
In wake of Q2 revenue drop, Charles River cuts 3% of workforce
Inflammatix collects $57M as it awaits FDA review of infectious disease test